209 related articles for article (PubMed ID: 8356724)
21. Survival of serologically HLA typed and matched cadaveric kidney transplants and patients: influence of serologic retyping of donors.
Thorogood J; Doxiadis II; Schreuder GM; Persijn GG; van Rood JJ
Transplant Proc; 1993 Dec; 25(6):3051-2. PubMed ID: 8266449
[No Abstract] [Full Text] [Related]
22. Simple and rapid HLA-DRB DNA typing method for transplantation using polymerase chain reaction-sequence-specific primers in combination with DNA conformation polymorphism analysis.
Shintaku S; Fukuda Y; Tashiro H; Hoshino S; Dohi K; Kimura A
Transplant Proc; 1994 Aug; 26(4):1893-6. PubMed ID: 8066616
[No Abstract] [Full Text] [Related]
23. The importance of tissue typing in cadaveric kidney transplantation (pros).
Sirchia G
Contrib Nephrol; 1982; (34):101-10. PubMed ID: 6756776
[No Abstract] [Full Text] [Related]
24. Histocompatibility. Influence of HLA-DR matching on renal graft survival. A Scandiatransplant report.
Moen T; Berger L; Goyer K; Dahl O; Thorsby E
Scand J Urol Nephrol Suppl; 1981; 64():30-7. PubMed ID: 6815792
[No Abstract] [Full Text] [Related]
25. Cadaveric kidneys should be allocated according to the HLA match.
Opelz G; Wujciak T
Transplant Proc; 1995 Feb; 27(1):93-9. PubMed ID: 7879235
[No Abstract] [Full Text] [Related]
26. Molecular analysis of graft survival in renal transplantation by DNA typing of HLA class II antigens.
Tsuji K; Inoko H; Ando A; Matsuno N; Ikewaki N; Sato T; Ichikawa Y; Sonoda T
Transplant Proc; 1987 Feb; 19(1 Pt 1):662-3. PubMed ID: 3152706
[No Abstract] [Full Text] [Related]
27. Long-term graft survival rate of zero-mismatch kidney transplants for HLA-DRB1.
Ichikawa Y; Fujimoto N; Hashimoto M; Kyo M; Kinoshita T; Takahara S; Yamasaki M; Ohshima S; Ihara H; Fukunishi T; Sata M; Amemiya HP; Hanafusa T; Nagano S
Transpl Int; 1994; 7 Suppl 1():S281-5. PubMed ID: 11271225
[TBL] [Abstract][Full Text] [Related]
28. Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing.
Leivestad T; Sødal G; Bratlie A; Albrechtsen D; Fauchald P; Pfeffer P; Vartdal F; Thorsby E
Transplant Proc; 1993 Feb; 25(1 Pt 1):220-1. PubMed ID: 8438277
[No Abstract] [Full Text] [Related]
29. [The dependence of the efficacy of cyclosporin A use in a kidney allograft on the degree of donor and recipient tissue compatibility based on HLA-DR antigens].
Abramov VIu; Kaluzhina NN; Otocheva LV; Zaretskaia IuM
Urol Nefrol (Mosk); 1993; (4):27-30. PubMed ID: 8310562
[TBL] [Abstract][Full Text] [Related]
30. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
Süsal C; Opelz G
Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
[TBL] [Abstract][Full Text] [Related]
31. Impact of flow cytometry cross-matching results on the outcome of cadaveric kidney transplantation.
Wahlberg J; Bengtsson M; Bergström C; Gannedahl G; Festin R; Lewen G; Frödin L
Transplant Proc; 1994 Jun; 26(3):1752-3. PubMed ID: 8030118
[No Abstract] [Full Text] [Related]
32. Influence of HLA-A,B and DR antigens on cadaver kidney transplantation in the Japanese.
Ohmori K; Yokoyama T; Kashiwabara H
Transplant Proc; 1983 Dec; 15(4):2142-4. PubMed ID: 6369683
[No Abstract] [Full Text] [Related]
33. Influence of donor/recipient HLA-DR antigen disparities on cadaver kidney graft survival: an alternative for recipient selection.
Vereerstraeten P; Andrien M; Dupont E; Kinnaert P; Toussaint C
Transplant Proc; 1989 Feb; 21(1 Pt 1):679-81. PubMed ID: 2650220
[No Abstract] [Full Text] [Related]
34. Comparison of HLA matching protocols to maximize the number of compatible kidney recipients in small Asian pools.
Takemoto S; Terasaki PI
Transplant Proc; 1994 Aug; 26(4):1879-80. PubMed ID: 8066611
[No Abstract] [Full Text] [Related]
35. Genomic HLA-DRB1 matching further improves clinical course after renal transplantation.
Leivestad T; Spurkland A; Knutsen I; Bratlie A; Vartdal F; Pfeffer P; Sødal G; Fauchald P; Thorsby E
Transplant Proc; 1995 Feb; 27(1):678-9. PubMed ID: 7879142
[No Abstract] [Full Text] [Related]
36. Polymerase chain reaction-based HLA-A genotyping and its application to matching in kidney transplantation.
Shintaku S; Kimura A; Fukuda Y; Date Y; Tashiro H; Hoshino S; Furukawa M; Sasazuki T; Dohi K
Transplant Proc; 1995 Feb; 27(1):689-92. PubMed ID: 7879147
[No Abstract] [Full Text] [Related]
37. HLA compatibility and organ transplant survival. Collaborative Transplant Study.
Opelz G; Wujciak T; Döhler B; Scherer S; Mytilineos J
Rev Immunogenet; 1999; 1(3):334-42. PubMed ID: 11256424
[TBL] [Abstract][Full Text] [Related]
38. HLA-DR matching: the impact on cadaveric renal transplantation. A single-center study.
Madsen M; Graugaard B; Fjeldborg O; Posborg V; Hansen HE; Lamm LU; Kissmeyer-Nielsen F
Scand J Urol Nephrol Suppl; 1981; 64():56-63. PubMed ID: 6815794
[No Abstract] [Full Text] [Related]
39. Comparison of clinical response of DR-matched, MLC-compatible cadaver renal allografts and those from HLA-identical related donors.
Conti DJ; Andersen R; Soper WD; Wolf JS
Transplant Proc; 1987 Feb; 19(1 Pt 1):652-4. PubMed ID: 2978928
[No Abstract] [Full Text] [Related]
40. Chimerism in survivors following allograft renal transplantation.
Lee JM; Lee CJ; Hu CY; Hsieh RP; Hu RH; Lee PH; Luh SP; Lee YC; Chu SH
Transplant Proc; 1996 Jun; 28(3):1285-7. PubMed ID: 8658662
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
